The first stop for professional medicines advice

Colistimethate Sodium products: information for supporting intrathecal risk assessment

Published
Topics: Aseptic servicesColistimethateInfection and infectious diseasesIntrathecal medicines

Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Contents
  1. Licensed for intrathecal use
    1. Beacon
    2. Noridem
    3. Panmedica
    4. Teva (Colomycin®)
  2. No information available

Licensed for intrathecal use

Products licensed for intrathecal use are the first line option and should be used wherever suitable.

Beacon

Strength

1 million International Units (IU)

Noridem

Strength

1 million International Units (IU)
2 million International Units (IU)

Panmedica

Strength

3 million International Units (IU)

Teva (Colomycin®)

Strength

1 million International Units (IU)
2 million International Units (IU)

No information available

Products with very little or no information are rarely used for intrathecal administration.

There are currently no known additional colistimethate sodium products.